-
For the new coronavirus SARS-CoV-2/COVID-19, The Latest Research Progress in the Journal of Science (No. 3)
Time of Update: 2020-07-30
Our scientists have structurally revealed a powerful therapeutic antibody and SARS-CoV-2 and SARS-CoV mechanism doi: 10.1126/science.abc5881 According to the World Health Organization (WHO), as of June 8, 2020, the 2019 coronavirus epidemic (COVID-19) pandemic has caused more than 7 million infections in more than 200 countries/regions and caused death.
-
Sci Rep: Prevalence of neck and shoulder pain among public hospital staff and its associated factors.
Time of Update: 2020-07-30
Due to the lack of NSP data, the study investigated the prevalence of NSP and sick leave absences among staff at public hospitals in Shandong, China, and looked at the factors associated with chronic NSP.
-
T-cells are expected to become targets for drugs that inhibit atherosclerosis.
Time of Update: 2020-07-30
in a new study, researchers found that some T lymphocytes, a type of white blood cell, initially tried to fight the disease, but could eventually exacerbate inflammation and make atherosclerosis worse.
using the new tracking method, Ley and colleagues identified a set of regulated T-cells that usually help reduce inflammation in the body.
-
Important research results focus on new advances in the field of peptide drug molecular research!
Time of Update: 2020-07-30
Photo credit: Science Translational Medicine, 2020, doi: 10.1126/scitranslmed.aaz7287 (Science Sub-journal: Using M3mP6 polypeptide high-load nanoparticles is expected to treat heart disease doi: 10.1126/sci In a new study, researchers at the University of Illinois at Chicago have developed a new drug that prevents blood clots and does not increase the risk of bleeding, a common side effect of all platelet drugs.
-
Clin Infect Dis: CoVID-19 patients improved after treatment for tozhu monotomonorotic.
Time of Update: 2020-07-29
July 19, 2020 /PRNewswire/ -- Most patients hospitalized with COVID-19 (coronavirus) pneumonia have improved after receiving FDA-approved medications for rheumatoid arthritis, according to an observat
-
Interpretation! Uncover the fine structure of the full-length RNA genome of SARS-CoV-2 in infected cells!
Time of Update: 2020-07-29
July 29, 2020 // The COVID-19 pandemic caused by the single-stranded RNA virus SARS-CoV-2 will infect humans across species, and has spread rapidly worldwide, with more than 10 million infections, COV
-
Nature's big break! Mitochondrial Ubiquinol oxidation is necessary for tumor growth!
Time of Update: 2020-07-29
July 17, 2020 /PRNewswire/ -- Numerous studies have shown that mitochondrial electron transfer chain (electron transport chain, ETC) is necessary for tumor growth, and studies that inhibit this proces
-
Nature: Anti-SARS-CoV-2 antibodies found to neutralise and protect the body.
Time of Update: 2020-07-29
July 17, 2020 /PRNewswire/ -- The COVID-19 pandemic is a major threat to global health, especially in areas where medical responses are limited In addition, we currently lack in-depth understanding of
-
Clin Infect Dis: Obese adults or are more susceptible to H1N1 influenza.
Time of Update: 2020-07-29
July 16, 2020 // In a recent study published in the international journal Clinical Infectious Diseases, scientists from the University of Michigan and others found that obese adults or people are more
-
Nat Commun: Accident! Cases of COVID-19 infection in the womb were detected!
Time of Update: 2020-07-29
July 19, 2020 /PRNewswire/ -- French doctors have described what they say is the first confirmed case of a newborn baby being infected with COVID-19 in the womb by his mother They recently reported in
-
Cell Rep: New research confirms that Redsewey can indeed be an effective treatment for COVID-19!
Time of Update: 2020-07-29
July 19, 2020 // In a recent study published in the international journal Cell Reports, scientists from Vanderbilt University Medical Center and others found that Redsewe may indeed be able to potenti
-
A selection of Lancet research highlights from July 25, 2020.
Time of Update: 2020-07-29
!---- Enquatabina used noofovir amine for HIV infection prevention DOI in high-risk populations: For HIV patients, the fenofoviraphenol amine is more advantageous in terms of antiviral effects and imp
-
July 3, 2020 Science Journal.
Time of Update: 2020-07-29
!--webeditor:page title"--July 11, 2020 // --- This week with the release of a new journal of Science (June 26, 2020), what are the great studies? Let the little ones come together Photo from the Jour
-
New anti-inflammatory drugs! Lilly mirikizumab treatment of moderate severe plaque-type psoriasis Phase III: better than Novartis Cosentyx (good) !
Time of Update: 2020-07-29
July 18, 2020 // Eli Lilly has announced the positive results of a new anti-inflammatory drug mirikizumab treatment for moderate-to-severe plaque psoriasis PHASE III OASIS-2 The results showed that mi
-
Science: The characteristics of patients with severe COVID-19 were found to be --- lack of type I interferon response and increased inflammation.
Time of Update: 2020-07-29
17(2020 /--- In a new study, researchers from France identified what they believe is typical of patients with severe COVID-19 The findings were published online July 13, 2020 in the journal Science, w
-
Nature accidentally found out! SARS-CoV-2 antibodies are present in non-infected people!
Time of Update: 2020-07-29
July 17, 2020 /PRNewswire/ -- Previouspathogen-induced memory T cells can alter susceptibility and clinical severity to subsequent infections Little is known about the presence of pre-existing memory
-
The first drug to develop interstitial pulmonary disease (PF-ILD) for fibrosis! Bollinger Ingham Ofev (Nidanib) EU approved for the third indication!
Time of Update: 2020-07-29
July 16, 2020 // Boehringer Ingelheim recently announced that the European Commission (EC) has approved of Ofev (Chinese: Vigat, generic name: nintedanib, Nidanib) for the treatment of other gliopathi
-
Science: Incomplete B-cell tolerance in early childhoods in human fetuses facilitates the accumulation of multi-reactive B cells.
Time of Update: 2020-07-29
July 19, 2020 // --- it has long been known that the acquired immune system can produce a large pool of antibodies (immunoglobulins) in developing B cells through the recombination of the V(D) J gene
-
7 articles reveal the many health risks faced by people living with HIV! From the largest AIDS co-existence disease research in history!
Time of Update: 2020-07-29
!--Webeditor:page title" -- A series of recent articles published by Journal of The Journal of The Disease reveal the impact and prevalence of heart disease and other severe complications on an aging
-
Cell Rep: A new mechanism for brain cancer resistance.
Time of Update: 2020-07-29
16, 2020 /UPI) -- --- A study by researchers at Uppsala University, which surveyed a large sample of cells in patients with brain tumors, found how changes in glioblastoma cells affect the effects of
